| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.091 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |